NIM
DGX icon

Northeast Investment Management’s Quest Diagnostics DGX Stock Holding History

Northeast Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,604
Closed -$200K – 167
2015
Q1 		$200K Buy
+2,604
New +$186K 0.02% 164

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northeast Investment Management's DGX Position: Q2 2015 in Review

Northeast Investment Management sold out of Quest Diagnostics (DGX) in Q2 2015, closing a stake of 2,604 shares — an estimated $200K sold.

Northeast Investment Management first reported a position in DGX in Q1 2015 and held it in 1 quarter. The position peaked at $200K in Q1 2015. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

  • Northeast Investment Management reported no remaining Quest Diagnostics position as of Q2 2015 after selling out during the quarter.
  • Northeast Investment Management sold 2,604 Quest Diagnostics shares in Q2 2015, an estimated $200K.
  • Northeast Investment Management first reported a position in Quest Diagnostics in Q1 2015 and held it in 1 quarter.
  • Northeast Investment Management's Quest Diagnostics position peaked at $200K in Q1 2015.
  • 542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on Northeast Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.